BUCOLO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 11.317
EU - Europa 5.045
AS - Asia 4.769
SA - Sud America 1.134
AF - Africa 650
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 22.938
Nazione #
US - Stati Uniti d'America 10.918
SG - Singapore 2.251
IT - Italia 1.988
CN - Cina 1.748
IE - Irlanda 1.028
BR - Brasile 1.004
UA - Ucraina 852
CI - Costa d'Avorio 402
CA - Canada 330
RU - Federazione Russa 268
DE - Germania 248
VN - Vietnam 175
KR - Corea 164
SN - Senegal 143
SE - Svezia 117
GB - Regno Unito 114
IN - India 96
FI - Finlandia 95
FR - Francia 50
PL - Polonia 49
AR - Argentina 48
JP - Giappone 47
BD - Bangladesh 44
CH - Svizzera 44
MX - Messico 42
NL - Olanda 36
ES - Italia 34
ZA - Sudafrica 32
HK - Hong Kong 30
ID - Indonesia 29
UZ - Uzbekistan 29
TR - Turchia 28
BE - Belgio 27
IQ - Iraq 26
EC - Ecuador 25
MA - Marocco 20
NG - Nigeria 19
GR - Grecia 18
AT - Austria 17
CO - Colombia 16
PK - Pakistan 15
LB - Libano 14
LT - Lituania 14
AE - Emirati Arabi Uniti 12
TN - Tunisia 12
AU - Australia 11
PY - Paraguay 10
CZ - Repubblica Ceca 9
EU - Europa 9
IR - Iran 9
PE - Perù 9
KE - Kenya 8
UY - Uruguay 8
HN - Honduras 7
JO - Giordania 7
VE - Venezuela 7
EG - Egitto 6
HR - Croazia 6
IL - Israele 6
AZ - Azerbaigian 5
CL - Cile 5
JM - Giamaica 5
RO - Romania 5
BG - Bulgaria 4
DZ - Algeria 4
NP - Nepal 4
OM - Oman 4
SA - Arabia Saudita 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
KZ - Kazakistan 3
MK - Macedonia 3
NI - Nicaragua 3
PT - Portogallo 3
TW - Taiwan 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
KG - Kirghizistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
Totale 22.926
Città #
Dallas 2.103
Santa Clara 1.504
Chandler 1.160
Singapore 1.136
Dublin 1.021
Jacksonville 860
Catania 599
Chicago 537
Boardman 442
Abidjan 402
Hefei 378
Ashburn 372
Nanjing 284
Lawrence 276
Cambridge 270
Andover 267
Beijing 240
Toronto 226
Houston 207
Seoul 161
Des Moines 144
Dakar 143
Los Angeles 141
San Mateo 126
Wilmington 119
Civitanova Marche 100
Grafing 82
São Paulo 82
Florence 76
Nanchang 76
New York 73
Shenyang 69
Ottawa 67
Rome 66
Saint Petersburg 66
The Dalles 62
Hebei 61
Council Bluffs 55
Ho Chi Minh City 54
Jiaxing 54
Palermo 54
Bremen 53
Columbus 53
Messina 50
Changsha 47
Tianjin 46
Rio de Janeiro 42
Lappeenranta 40
Tokyo 40
Munich 37
Seattle 37
Hanoi 36
Brooklyn 35
Buffalo 35
Aci Catena 34
Warsaw 34
Belo Horizonte 32
Milan 32
Redwood City 31
Naples 29
San Francisco 29
Dong Ket 27
Falls Church 27
Moscow 27
Dearborn 25
Helsinki 25
Hong Kong 23
Orem 23
Redondo Beach 23
Washington 23
Curitiba 22
Pune 22
Turku 22
Belpasso 21
Brussels 21
Hangzhou 21
Montreal 21
Phoenix 21
Johannesburg 20
Ningbo 20
Pozzallo 20
Denver 19
Stockholm 19
Abuja 18
Guangzhou 18
Jinan 18
Liberty Lake 18
London 18
Norwalk 18
Zhengzhou 18
Brasília 16
Atlanta 15
Boston 15
Lissone 15
Mumbai 15
Shanghai 15
Bronte 13
Den Haag 13
Jakarta 13
Mexico City 13
Totale 15.748
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 232
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 225
Current drug treatments targeting dopamine D3 receptor 199
Dopaminergic-GABAergic interplay and alcohol binge drinking 183
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 176
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 171
Antioxidant and osmoprotecting activity of taurine in dry eye models 153
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 145
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 140
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 139
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 138
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 137
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 136
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 136
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 134
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 132
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 130
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 130
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 127
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 126
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 126
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 125
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 124
Caffeine Protects Against Retinal Inflammation 119
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 118
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 118
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 118
Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells 116
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 116
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 114
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 113
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 109
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 109
Prognostic significance of deregulated microRNAs in uveal melanomas 108
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 107
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 107
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 103
Controversies in Glaucoma: Current Medical Treatment and Drug Development 103
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 101
P2X7 receptor antagonism: implications in diabetic retinopathy 100
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 99
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 98
Acidic mammalian chitinase in dry eye conditions 98
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 98
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 98
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 98
Fluoxetine Protects Retinal Ischemic Damage in Mice 97
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 97
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 97
Rapid determination of nimesulide in rabbit aqueous humor by liquid chromatography 96
A prolonged release polymeric nanocarrier for ocular administration 96
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 95
Carnosol attenuates high glucose damage in human retinal endothelial cells through regulation of ERK/Nrf2/HO-1 pathway 94
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 94
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 93
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 92
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 92
Retinal protection and distribution of curcumin in vitro and in vivo 92
Novel therapeutics in glaucoma management 91
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 90
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 90
Ruolo fisiologico del monossido d’azoto e monossido di carbonio nella modulazione della pressione endoculare 90
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 90
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 90
Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis 90
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 89
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 89
The immune system on the TRAIL of Alzheimer’s disease 89
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 88
"In Vivo" Evaluation of Biocompatibility and Biodegradation of Different Hyaluronan Derivatives Intravitreal Implants with Ultrasound Biomicroscopy. 88
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 88
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 88
Evaluation of tolerability of a series of lipoamino acids using biological membranes and a biomembrane model 87
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 87
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 86
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 86
Protective effects of a coumarin derivative in diabetic rats 86
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 86
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 86
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma 85
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease 85
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 85
Valutazione del tempo di bioerosione di inserti intravitreali a base di esteri dell'acido ialuronico 85
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 85
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 85
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 84
Farmacologia Oculare 84
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 84
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 84
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage 84
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 83
Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients 83
L'acido Ialuronico come Carrier Ideale nella Veicolazione Topica Oculare del Timololo 83
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes 83
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 83
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice 83
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 83
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 82
Ocular pharmacokinetics profile of different indomethacin topical formulations. 82
Lipoprotein(a) serum levels in diabetic patients with retinopathy 82
Totale 10.678
Categoria #
all - tutte 85.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.231 0 0 0 0 425 53 209 10 211 43 186 94
2021/20222.151 242 278 44 32 305 58 318 92 210 38 71 463
2022/20233.666 317 175 54 374 395 598 37 617 858 46 131 64
2023/20241.588 117 230 87 106 83 326 27 118 12 25 276 181
2024/20256.437 81 997 324 319 1.341 725 324 274 552 573 464 463
2025/20265.488 811 735 2.465 856 621 0 0 0 0 0 0 0
Totale 23.516